Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.955 USD | +5.16% | -1.83% | +73.82% |
May. 07 | Transcript : Heron Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 126
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic Innovations
100.0
%
| 108 | 100.0 % | 127 | 100.0 % | +17.99% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 108 | 100.0 % | 127 | 100.0 % | +17.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 23-02-20 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 23-06-15 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 18-10-31 |
Chief Tech/Sci/R&D Officer | 65 | 12-03-29 | |
John C. Arthur
PRN | Corporate Officer/Principal | 58 | 16-12-31 |
Sean T. Ristine
HRO | Human Resources Officer | 54 | 14-07-31 |
William Forbes
PRN | Corporate Officer/Principal | 62 | 23-06-05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 23-02-20 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 21-09-19 |
Craig Johnson
BRD | Director/Board Member | 62 | 14-01-12 |
Christian Waage
BRD | Director/Board Member | 57 | 16-06-21 |
Adam Morgan
CHM | Chairman | 45 | 23-02-20 |
Director/Board Member | 49 | 21-09-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 150,653,158 | 149,609,560 ( 99.31 %) | 0 | 99.31 % |
Company contact information
Heron Therapeutics, Inc.
4242 Campus Point Court Suite 200
92121, San Diego
+858 251 4400
http://www.herontx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+73.82% | 423M | |
+28.65% | 49.18B | |
+0.81% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.38% | 26.09B | |
-22.40% | 18.71B | |
+8.02% | 13.26B | |
+31.92% | 12.32B | |
-0.49% | 11.99B |
- Stock Market
- Equities
- HRTX Stock
- Company Heron Therapeutics, Inc.